Functional scales and motor assessment in Amyotrophic Lateral Sclerosis

Author(s): Benaim C, Desnuelle C, Fourniere-Mehouas M

Abstract

There is a need of standardized and quantitative clinical assessments of ALS patients receiving new treatments. Some clinical scales, that are based on patients interviews and/or on physical examination, allow to quantify the patient functional status over time. The ALSFRS has been validated for that purpose and is one the most commonly used scales in clinical trials. Its revised version (the ALSFRS-R) has recently shown excellent metric properties. Functional scales are part of the clinical evaluation of ALS patients, and complete the quantitative assessment of muscle strength, that includes the Manual Muscular Testing (MMT) and the Maximal Voluntary Isometric Contraction (MVIC). Readers will find in this article a (non-exhaustive) listing of functional and motor scales that can be useful both in clinical trials of experimental agents and in daily practice.

Similar Articles

Contribution of major amyotrophic lateral sclerosis genes to the etiology of sporadic disease

Author(s): Lattante S, Conte A, Zollino M, Luigetti M, Del Grande A, et al.

Amyotrophic Lateral Sclerosis – Frontotemporal Spectrum Disorder (ALS-FTSD): Revised diagnostic criteria

Author(s): Strong MJ, Abrahams S, Goldstein LH, Wooley S, Mclaughlin P, et al.

Genetic counselling in ALS: facts, uncertainties and clinical suggestions

Author(s): Chiò A, Battistini S, Calvo A, Caponnetto C, Conforti FL, et al.

New ALS-Related Genes Expand the Spectrum Paradigm of Amyotrophic Lateral Sclerosis

Author(s): Sabatelli M, Marangi G, Conte A, Tasca G, Zollino M, et al.

ATXN1 intermediate-length polyglutamine expansions are associated with amyotrophic lateral sclerosis

Author(s): Lattante S, Pomponi MG, Conte A, Marangi G, Bisogni G, et al.

Pathological laughing and crying in amyotrophic lateral sclerosis

Author(s): McCullagh S, Moore M, Gawel M, Feinstein A

The El Escorial criteria: strengths and weakessnes

Author(s): Agosta F, Al-Chalabi A, Filippi M, Hairdman O, Kaji R, et al.

Cognitive changes predict functional decline in ALS: a polupaltion-based longitudinal study

Author(s): Elamin M, Bede P, Byrne S, Jordan N, Gallagher L, et al.

Cognitive functioning in sporadic amyotrophic lateral sclerosis: A six month longitudinal study

Author(s): Robinson KM, Lacey SC, Grugan P, Glosser G, Grossman M, et al.

Premorbid personality characteristics of patients with ALS

Author(s): Grossman AB, Bonnie EL, Bradley WG

Emotional Adjustment in Amyotrophic Lateral Sclerosis (ALS)

Author(s): Lulè D, Paulì S, Altinas E, Singer U, Mèrk T, et al.

Prevalence of Fatigue and depression in ALS patients and change over time

Author(s): McElhiney MC, Rabkin JC, Gordon PH, Goetz R, Mitsumoto H

Deficits in emotional and social cognition in Amyotrophic Lateral Sclerosis

Author(s): Girardi A, MacPherson SE, Abrahams S

Amyotrophic lateral sclerosis and frontotemporal dementia: A behavioural and cognitive continuum

Author(s): Lillo P, Savage S, Mioshui E, Kiernan MC, Hodges JR

La diagnosi in psichiatria

Author(s): Frances A

The cognitive profiles of ALS: A systematic review and meta-analisis update

Author(s): Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, et al.

The Amyotrophic Lateral Sclerosis Functional Rating Scale

Author(s): ALS CNTF Treatment Study (ACTS) Phase I-II Study Group

The validation of the Italian Edinburgh Cognitive and Behavioural ALS Screen (ECAS)

Author(s): Poletti B, Solca F, Carelli L, Madotto F, Lafronza A, et al.